Sickle cell gene editing faces market hurdles: Analyst
The FDA approved a gene editing treatment for sickle cell disease to alleviate severe, recurrent pain crises. Casgevy, developed by Vertex Pharmaceuticals (VRTX) and...
Stocks tread water with CPI data, Fed on the horizon
Stocks were little changed on Monday morning, signaling a muted start to a week packed with a crucial inflation update and the Federal Reserve's...
US futures tread water with CPI data, Fed on the horizon
US stock futures were little changed on Monday, signaling a muted start to a week packed with a crucial inflation update and the Federal...
First National Financial Corporation (TSE:FN) insiders seem bullish, own 38% and have been buying more recently
Key InsightsFirst National Financial's significant insider ownership suggests inherent interests in company's expansionA total of 2 investors have a majority stake in the company...
